Molecular epidemiology of the community-associated methicillin-resistant staphylococcus aureus clones: a synthetic review
- PMID: 29440945
- PMCID: PMC5808271
- DOI: 10.15386/cjmed-807
Molecular epidemiology of the community-associated methicillin-resistant staphylococcus aureus clones: a synthetic review
Abstract
The article presents a synthetic molecular characterization of the methicillin-resistant Staphylococcus aureus and describes the most important community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) clones that circulate nowadays in the world: the main molecular and epidemiological characteristics, as well as notions related to the clinic of infections produced by these clones and their antibiotic resistance spectrum. The predominant clone of CA-MRSA in North America is USA300 - ST8-IV in North America, in Australia - Queensland (Qld) MRSA (ST93-IV), in Europe - ST80-IV, in Asia there is a high heterogeneity of clones population, in Africa the distribution of CA-MRSA clones is unclear, and in South America - USA 1100 and USA300-Latin American variant are predominant. The molecular diagnosis is performed by highly specialized institutions. The knowledge of clones allows the study of antibiotic resistance spectrum for each one, a fact of great importance for medical practice. Molecular epidemiology of the CA-MRSA shows that lowly restricted sales of antibiotics in shops and pharmacies, as well as medical prescribing practices without a laboratory investigation, especially in Eastern Europe and Asia, contribute to the development of new MRSA clones with increased resistance to antibiotics.
Keywords: CA-MRSA; Staphylococcus aureus; clones.
Figures
References
-
- Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520–532. - PubMed
-
- Jevons MP. “Celbenin”-resistant staphylococci. BMJ. 1961;1:124–125.
-
- Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39(7):971–979. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources